Award
Delivery Order #36C25926F0197
Delivery Order for Lenalidomide RX to EXELAN Pharmaceuticals Inc.
Buyer
Department of Veterans Affairs
Award Amount
$2,426,314.08
Ceiling
$2,426,314.08
Awarded
May 18, 2026
Period of Performance
May 18, 2026 – May 17, 2027
Identifier
36C25926F0197
NAICS
325412
This award represents a significant delivery order contract issued to EXELAN Pharmaceuticals Inc., a U.S.-incorporated foreign-owned pharmaceutical company specializing in providing essential drug products. The contract procures Lenalidomide RX, a critical pharmaceutical product, reinforcing the ongoing supply chain for healthcare needs. This award builds upon EXELAN’s existing multi-year indefinite delivery vehicle contract under the Federal Supply Schedule with the Department of Veterans Affairs. The work scope includes timely provision and delivery of Lenalidomide RX over a one-year performance period, addressing urgent medical supply requirements. The contract supports the agency’s strategic goal to maintain uninterrupted access to vital medications for patient care. Awarded through a competitive process as part of a broader IDV contract, this delivery order ensures continuity and reliability in pharmaceutical procurement. The performance period begins in mid-2026, continuing for one year, exemplifying sustained collaboration between the agency and EXELAN Pharmaceuticals.
Description
LENALIDOMIDE RX